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• Gastroesophageal reflux is a 
widely prevalent disease
• Long-term PPI use has adverse 
effects on patient
• TIF and LINX procedures 
provide
– Improved GERD related QoL
– Decreased medication burden on 
patient
LVHN Reflux Treatment Program: A Pilot Study
Evaluating the value of two novel procedural techniques in treating 
GERD vs standard medical therapy. A multidisciplinary approach
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• Prospective study of participants > 
18yo w/ GERD and PPI use > 1 
month
• Symptoms occurring ≥ 2-3 
days/week w/ no to minimal 
improvement on PPI
• No hx of Barrett’s esophagus, 
esophageal stricture, systemic 
sclerosis, esophageal 
adenocarcinoma
• Patients undergo PPI trial, EGD, pH 
monitoring, and esophageal 
manometry
• Patients’ QoL is assessed via GERD-
HRQL
• Undergo either TIF or LINX after 
discussion with care team
• Stop PPI use 2 weeks post-op
• Reassess w/ GERD-HRQL at 6-
month follow-up
• Patient GERD-HRQL average 
score at initial encounter of 
~29
• Decreased significantly to 0 at 
6-month follow-up
• Limited patient pool but 
positive results in patient 
symptoms without PPI use at 6 
months
• Can reduce patient medication 
burden and increase QoL
• Values Based Patient 
Centered Care
• Multidisciplinary team 
approach to care
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Patient 1 TIF 24 0
Patient 2 TIF 32 0
Patient 3 LINX 30 0
Average 28.67 0
Pilot project assessing the TIF and LINX 
procedures’ effect on patient QoL at 6-
month follow-up using the GERD-HRQL
• Normal swallowing involves passage of 
food from mouth through esophagus 
to stomach
• GERD is symptomatic regurgitation 
from stomach to esophagus
• Prevalence of 19.8% in the US1
• Treatment w/ PPI is mainstay of 
medical therapy
• Nissen Fundoplication is the “gold 
standard” for surgical intervention 
• Transoral Incisionless Fundoplication
• Utilizes Esophyx device to suture 
fundus of stomach to distal esophagus
• FDA approved in 2009
• Meta-analysis demonstrated a 
cessation of PPI use in 89% of patients 
in 5 year follow-up2
• LINX magnetic core band
• Titanium beads wrapped around the 
LES
• FDA Approved in 2012
• Significant reduction in PPI use and 
increased QoL at 5-year follow-up3
GERD-HRQL4
Background Methods Discussion
Results
Conclusions
